424870 Stock Chart & Stats
₩2755.00
-₩90.00(-3.16%)
―
--
Day’s Range― - ―
52-Week Range₩2,300.00 - ₩15,489.81
Previous CloseN/A
VolumeN/A
Average Volume (3M)205.32K
Market Cap
₩251.63B
Enterprise Value₩200.44K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Nov 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-47.58
Shares Outstanding91,337,510
10 Day Avg. Volume107,533
30 Day Avg. Volume205,325
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
424870 FAQ
What was ImmuneOncia Therapeutics Inc.’s price range in the past 12 months?
ImmuneOncia Therapeutics Inc. lowest stock price was ₩2300.00 and its highest was ₩15489.81 in the past 12 months.
What is ImmuneOncia Therapeutics Inc.’s market cap?
ImmuneOncia Therapeutics Inc.’s market cap is ₩251.63B.
When is ImmuneOncia Therapeutics Inc.’s upcoming earnings report date?
ImmuneOncia Therapeutics Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 61 days.
How were ImmuneOncia Therapeutics Inc.’s earnings last quarter?
ImmuneOncia Therapeutics Inc. released its earnings results on Aug 14, 2026. The company reported -₩47.584 earnings per share for the quarter.
Is ImmuneOncia Therapeutics Inc. overvalued?
According to Wall Street analysts ImmuneOncia Therapeutics Inc.’s price is currently Undervalued.
Does ImmuneOncia Therapeutics Inc. pay dividends?
ImmuneOncia Therapeutics Inc. does not currently pay dividends.
What is ImmuneOncia Therapeutics Inc.’s EPS estimate?
ImmuneOncia Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImmuneOncia Therapeutics Inc. have?
ImmuneOncia Therapeutics Inc. has 91,337,510 shares outstanding.
What happened to ImmuneOncia Therapeutics Inc.’s price movement after its last earnings report?
ImmuneOncia Therapeutics Inc. reported an EPS of -₩47.584 in its last earnings report. Following the earnings report the stock price went down -0.455%.
Which hedge fund is a major shareholder of ImmuneOncia Therapeutics Inc.?
Currently, no hedge funds are holding shares in KR:424870
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
HLB PHARMACEUTICAL CO., LTD.
―
Kolon Life Science Inc.
―
EuBiologics Co., Ltd.
―
SillaJen, Inc.
―
NeoImmuneTech Inc shs Korean Deposit Receipt Repr 1/5 Sh
―